1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Inotuzumab Ozogamicin: new trials by email Literature Review of Inotuzumab Ozogamicin trials Research Report on Inotuzumab Ozogamicin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Full-Course Immunotherapy Consolidation for Unfit or Fit B-ALL Who Decline Chemotherapy Blinatumomab and Inotuzumab Ozogamicin - Acute Lymphoblastic Leukemia, Immunotherapy | Phase 2 | Recruiting | The First Affiliated Hospital of Soochow University | 26 | 2025-05-17 | 2026-03-24 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Leukemia (1) · Leukemia, Lymphoid (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
Inotuzumab Ozogamicin (1) · blinatumomab (1)
The First Affiliated Hospital of Soochow University (1)
China (1)